Research Site — Indianapolis, Indiana

Research Site is a clinical research site located in Indianapolis, Indiana, United States 46202.

Crixeo Health Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.

Research Site has participated in 228 clinical trials with 35 currently active.

Therapeutic areas: Advanced Squamous Non-Small Cell Lung Cancer, N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma, Advanced Breast Cancer.

Sponsors: NantCell, Inc., EMD Serono, AstraZeneca.

Sponsor Feasibility Report

Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Site?

Research Site has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Site conducted?

Research Site has 228 clinical trials on record, with 35 currently active. Their work covers Advanced Squamous Non-Small Cell Lung Cancer, N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma, Advanced Breast Cancer.

Is Research Site accredited by Crixeo Health?

Research Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Research Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.